Nektar Therapeutics · 10 hours ago
Sr. Director, Clinical Development (MD)
Nektar Therapeutics is seeking a Sr. Director of Clinical Development (MD) to oversee clinical trials and research activities. The role involves directing human clinical trials, managing clinical development plans, and ensuring adherence to protocols while collaborating with various departments and external partners.
Responsibilities
Consistently works on abstract problems across functional areas of clinical development
Identifies and evaluates fundamental issues, providing strategy and direction for major functional areas involved with clinical development of pharmaceutical/biotech products
Interacts internally and externally with executive level management requiring negotiation of extremely difficult matters to influence policymaking bodies
Oversees the development and management of Clinical Development Plans (CDP) which includes timelines, budget, and resource requirements
Ensures the development and implementation of clinical program strategy and directs those systems and programs in order to meet Company goals and objectives
Oversees the design of pivotal clinical studies for product and registration
Identifies and develops collaborations with external investigators and opinion leaders
Responsible for working closely with groups such as, Clinical Research, Regulatory Affairs, Clinical Operations, Marketing and Business Development
Acts as a clinical opinion leader working with physicians at a peer level
Oversees and coordinates efforts to address medical and scientific issues
Provides clinical analysis and promulgates scientific and clinical support for expansion of market share of Company products
Provides guidance to the business in the development of promotional materials and the training of product representatives
Oversees and performs medical monitoring
Drives the development of publications arising from studies and other relevant initiatives
Acts as a mentor to junior staff
Remains current with medical developments and publications on similar and competitor products
Applies this knowledge to current programs
May have responsibility for internal staffing and performance management, including hiring, training, coaching and performance reviews
Qualification
Required
An MD degree is required
A minimum of 9 years relevant clinical development experience is required
Must be able to demonstrate extensive experience in the design of clinical studies
A minimum of 5 years previous management experience may be required
Must have a demonstrated ability to solve problems with innovative solutions along with strong organizational skills
Excellent written and verbal communication skills are required
Previous experience working with senior management is required
Experience in conducting formal presentations to Sr. Management and key opinion leaders is required
Must have knowledge of effective competitive strategies as well as an in-depth understanding of clinical product development in the pharmaceutical industry
Strong analytical skills, especially with regard to understanding and interpreting scientific research and literature are essential
Experience and understanding of ICH, and GCP is required
Preferred
Experience in Dermatology / Immunology strongly preferred
Knowledge of GMP and GLP is preferred
Benefits
Health Insurance (Medical/Dental/Vision)
Disability Insurance
Holiday Pay
Paid Time Off (PTO)
401(k) Match
Employee Stock Purchase Plan
Wellness Programs
Parental Leave Benefits (in accordance with the terms of applicable plans)
Company
Nektar Therapeutics
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
H1B Sponsorship
Nektar Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (1)
2023 (3)
2022 (14)
2021 (15)
2020 (13)
Funding
Current Stage
Public CompanyTotal Funding
$1.31BKey Investors
SFJ PharmaceuticalsAstraZenecaDeerfield
2025-07-01Post Ipo Equity· $115M
2024-11-04Acquired
2024-03-04Post Ipo Equity· $30M
Leadership Team
Recent News
New Enterprise Associates
2026-01-13
MarketScreener
2026-01-03
Company data provided by crunchbase